Geneva University Neurocenter
Giovanni Frisoni

Giovanni Frisoni

Group name: Laboratory of Neuroimaging of Aging

Affiliations: Faculty of Medicine, Geneva University Hospitals, Department of Psychiatry

Domains: Development and Plasticity

Keywords: Alzheimer's disease, biomarkers, health care

Research activities

The group has over 20 years of experience in clinical and translational research on Alzheimer’s disease. The main scientific interest is the use of neuroimaging techniques and other biomarkers in persons with or at risk for cognitive impairment. Acquisitions and innovations in fundamental neurosciences, ICT, and technology are uptaken and translated for use into a clinical setting for better pathophysiological understanding, diagnosis, prognosis, disease tracking, drug therapy, and rehabilitation. Specific topics of investigation are: the clinical use of imaging and fluid biomarkers; in vivo neurobiology of Alzheimer’s disease; the clinical use of innovative PET ligands; harmonisation of imaging markers for clinical use; development of innovative image analysis environments based on advanced ICT technology.

Latest publications

Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex.

Ossenkoppele R , Coomans EM , Apostolova LG , Baker SL , Barthel H , Beach TG , Benzinger TLS , Betthauser T , Bischof GN , Bottlaender M , Bourgeat P , den Braber A , Brendel M , Brickman AM , Cash DM , Carrillo MC , Coath W , Christian BT , Dickerson BC , Dore V , Drzezga A , Feizpour A , van der Flier WM , Franzmeier N , Frisoni GB , Garibotto V , van de Giessen E , Domingo-Gispert J , Gnoerich J , Gu Y , Guan Y , Hanseeuw BJ , Harrison TM , Jack CR , Jaeger E , Jagust WJ , Jansen WJ , La Joie R , Johnson KA , Johnson SC , Kennedy IA , Kim JP , van Laere K , Lagarde J , Lao P , Luchsinger JA , Kern S , Kreisl WC , Malotaux V , Malpetti M , Manly JJ , Mao X , Mattsson-Carlgren N , , Messerschmidt K , Minguillon C , Mormino EM , O'Brien JT , Palmqvist S , Peretti DE , Petersen RC , Pijnenburg YAL , Pontecorvo MJ , Poirier J , , Rabinovici GD , Rahmouni N , Risacher SL , Rosa-Neto P , Rosen H , Rowe CC , Rowe JB , Rullmann M , Salman Y , Sarazin M , Saykin AJ , Schneider JA , Schöll M , Schott JM , Seo SW , Serrano GE , Shcherbinin S , Shekari M , Skoog I , Smith R , Sperling RA , Spruyt L , Stomrud E , Strandberg O , Therriault J , Xie F , Vandenberghe R , Villemagne VL , Villeneuve S , Visser PJ , Vossler H , Young CB , Groot C , Hansson O
Nature neuroscience - Jul 2025

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.

Jessen F , Arbizu J , Boada M , Balasa M , Bennys K , Boban M , Bürger K , Chincarini A , Cagnin A , De Deyn PP , Düzel E , Engelborghs S , Ewers M , Exalto LG , van der Flier WM , Fortea J , Frederiksen KS , Frisoni GB , Frölich L , Garza-Martinez AJ , Grimmer T , Hanseeuw B , Hort J , Ivanoiu A , Kehoe PG , Kennelly SP , Kern S , Klöppel S , Krajčovičová L , Kramberger MG , McGuinness B , Mecocci P , Oberstein TJ , Ousset PJ , Paquet C , Perneczky R , Piazza F , Plantone D , Rainero I , Sacco G , Salmon E , Santana I , Scarmeas N , Schneider A , Schott JM , Solje E , Stefanova E , Stögmann E , Strauss M , Sutovsky S , Waldemar G , Winblad B
The journal of prevention of Alzheimer's disease.. - Jul 2025
See the complete list of the publications

Contact

Département de psychiatrie
HUG
Email: Giovanni.Frisoni@hcuge.ch